Literature DB >> 11564963

Treatment of giardiasis reverses "active" coeliac disease to "latent" coeliac disease.

A Carroccio1, F Cavataio, G Montalto, F Paparo, R Troncone, G Iacono.   

Abstract

In patients with coeliac disease, a regression of intestinal damage without a gluten-free diet is a very rare event. We describe a young child with diarrhoea, intestinal mucosa atrophy and positive serum anti-endomysial and anti-tissue transglutaminase (anti-tTG) antibodies during intestinal giardiasis infection. He showed normal intestinal mucosa architecture and negative anti-endomysial and anti-tTG antibodies after his giardiasis was cured, although he continued to assume a normal diet. Re-evaluations on a 6-monthly basis showed that he was symptom free, and all haemato-chemical parameters were within normal limits. Three years after the initial diagnosis, a third intestinal biopsy showed: normal mucosa architecture; an increase in the intra-epithelial CD3+ and gamma/delta+ lymphocyte counts; and immunoglobulin-A anti-endomysial antibody detection in the supernatant of the intestinal mucosa culture incubated with gliadin. An active coeliac disease status, with intestinal mucosa atrophy, may regress to a latent coeliac disease status with normal intestinal mucosa histology after removal of the environmental factors that have presumably precipitated mucosa damage. Serum anti-endomysial and anti-tTG antibody behaviour is not a permanent, life-long feature and this must recommend the repetition of anti-endomysial or anti-tTG antibody assays in the same patient whenever coeliac disease diagnosis is again suspected, irrespective of previous negativity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564963     DOI: 10.1097/00042737-200109000-00018

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

Review 1.  Genetic and Environmental Contributors for Celiac Disease.

Authors:  Gloria Serena; Rosiane Lima; Alessio Fasano
Journal:  Curr Allergy Asthma Rep       Date:  2019-07-18       Impact factor: 4.806

Review 2.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 3.  Celiac disease: should we care about microbes?

Authors:  Alberto Caminero; Elena F Verdu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-12       Impact factor: 4.052

4.  Silent celiac disease activated by pancreaticoduodenectomy.

Authors:  John T Maple; Randall K Pearson; Joseph A Murray; Darlene G Kelly; Luis F Lara; Andy C Fan
Journal:  Dig Dis Sci       Date:  2007-03-21       Impact factor: 3.199

5.  Celiac Disease in an Adoptive Child with Recurrent Giardia Infection.

Authors:  Hyppolite K Tchidjou; Arianna De Matteis; Laura Di Iorio; Andrea Finocchi
Journal:  Int J Health Sci (Qassim)       Date:  2015-04

Review 6.  Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease.

Authors:  Jordan Voisine; Valérie Abadie
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

Review 7.  Immune development and intestinal microbiota in celiac disease.

Authors:  Tamara Pozo-Rubio; Marta Olivares; Esther Nova; Giada De Palma; Jorge R Mujico; Maria Desamparados Ferrer; Ascensión Marcos; Yolanda Sanz
Journal:  Clin Dev Immunol       Date:  2012-09-11

8.  Contributions of HLA haplotypes, IL8 level and Toxoplasma gondii infection in defining celiac disease's phenotypes.

Authors:  Mohammad Rostami-Nejad; Seyed Hossein Hejazi; Amado Salvador Peña; Hamid Asadzadeh-Aghdaei; Kamran Rostami; Umberto Volta; Mohammad Reza Zali
Journal:  BMC Gastroenterol       Date:  2018-05-18       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.